摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Fluoroadamantane-1-carbaldehyde | 1431957-10-6

中文名称
——
中文别名
——
英文名称
3-Fluoroadamantane-1-carbaldehyde
英文别名
——
3-Fluoroadamantane-1-carbaldehyde化学式
CAS
1431957-10-6
化学式
C11H15FO
mdl
——
分子量
182.238
InChiKey
LQHDJJBPJNEGEN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-Fluoroadamantane-1-carbaldehyde盐酸羟胺 、 potassium hydroxide 作用下, 以 甲醇 为溶剂, 反应 4.5h, 生成 3-[4-[[(3-fluoro-1-adamantyl)methylamino]methyl]phenyl]-N-hydroxyprop-2-enamide
    参考文献:
    名称:
    Discovery of adamantane based highly potent HDAC inhibitors
    摘要:
    Herein, we report the development of highly potent HDAC inhibitors for the treatment of cancer. A series of adamantane and nor-adamantane based HDAC inhibitors were designed, synthesized and screened for the inhibitory activity of HDAC. A number of compounds exhibited GI(50) of 10-100 nM in human HCT116, NCI-H460 and U251 cancer cells, in vitro. Compound 32 displays efficacy in human tumour animal xenograft model. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2013.03.002
  • 作为产物:
    描述:
    1-氟-3-金刚烷羧酸 在 dimethyl sulfide borane 、 pyridinium chlorochromate 作用下, 以 四氢呋喃 为溶剂, 反应 5.0h, 生成 3-Fluoroadamantane-1-carbaldehyde
    参考文献:
    名称:
    Discovery of adamantane based highly potent HDAC inhibitors
    摘要:
    Herein, we report the development of highly potent HDAC inhibitors for the treatment of cancer. A series of adamantane and nor-adamantane based HDAC inhibitors were designed, synthesized and screened for the inhibitory activity of HDAC. A number of compounds exhibited GI(50) of 10-100 nM in human HCT116, NCI-H460 and U251 cancer cells, in vitro. Compound 32 displays efficacy in human tumour animal xenograft model. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2013.03.002
点击查看最新优质反应信息

文献信息

  • 4-Carbamoylimidazol-5-ol derivatives, their production and pharmaceutical compositions containing them
    申请人:SUMITOMO CHEMICAL COMPANY, LIMITED
    公开号:EP0028936A2
    公开(公告)日:1981-05-20
    Compounds of the formula wherein R is an adamantoyl group having at least one substituent selected from halogen atoms, lower alkyl, lower alkoxy, hydroxy, alkanoyloxy, aroyloxy, acetamido, nitro, azide, trifluoromethyl, phenyl, nitrophenyl, halophenyl, lower alkylphenyl, and lower alkoxyphenyl groups are novel and are useful as antitumor agents and/or immunosuppressants.
    式中的化合物 其中 R 是金刚烷酰基,该基团具有至少一个选自卤素原子、低级烷基、低级烷氧基、羟基、烷酰氧基、酰氧基、乙酰基、硝基、叠氮基、三甲基、苯基、硝基苯基、卤化苯基、低级烷基苯基和低级烷氧基苯基的取代基。
  • US4332806A
    申请人:——
    公开号:US4332806A
    公开(公告)日:1982-06-01
查看更多